SCHEMBL4331233

SCHEMBL4331233

CCNC(=O)c1sc2nc(SC)nc(-c3cccc(OC)c3)c2c1N

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LHCGR P22888 8/20 0.77
TSHR P16473 2/20 0.77
FSHR P23945 1/20 0.54
BRAF P15056 2/20 0.53
PDE4A P27815 1/20 0.53
PDE4B Q07343 1/20 0.53
PDE4C Q08493 1/20 0.53
PDE4D Q08499 1/20 0.53
CHRM4 P08173 4/20 0.51
MAPT P10636 2/20 0.47
RXFP1 Q9HBX9 1/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
FLT1 P17948 1/20 0.44
LRRK2 Q5S007 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4322522 0.92 LHCGR (0.81) LHCGRTSHRFSHRBRAFPDE4A
SCHEMBL4325451 0.91 LHCGR (0.75) LHCGRTSHRFSHRBRAFPDE4A
SCHEMBL17467741 0.91 LHCGR (0.82) LHCGRTSHRFSHRBRAFPDE4A
SCHEMBL4329961 0.90 LHCGR (0.73) LHCGRTSHRFSHRBRAFPDE4A
SCHEMBL4331127 0.90 LHCGR (0.76) LHCGRTSHRFSHRBRAFPDE4A
SCHEMBL6927090 0.90 LHCGR (0.64) LHCGRTSHRFSHRBRAFPDE4A
SCHEMBL4328116 0.89 LHCGR (0.71) LHCGRTSHRFSHRBRAFPDE4A
SCHEMBL6427025 0.88 LHCGR (0.78) LHCGRTSHRFSHRBRAFPDE4A
SCHEMBL4335341 0.87 LHCGR (0.77) LHCGRTSHRFSHRBRAFPDE4A
SCHEMBL4326072 0.87 LHCGR (1.00) LHCGRTSHRFSHRBRAFPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160024023-A1 LOW MOLECULAR WEIGHT THYROID STIMULATING HORMONE RECEPTOR (TSHR) AGONISTS THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF 2016-01-28 US disclosed
US-20090203716-A1 Pyrimidine low molecular weight ligands for modulating hormone receptors The Government of the United States of America as represented by the Secretary of the 2009-08-13 US disclosed
US-6569863-B1 Luteinizing hormone (LH) agonists for controlling fertility AKZO NOBEL NV (NL) 2003-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024023-A1 LOW MOLECULAR WEIGHT THYROID STIMULATING HORMONE RECEPTOR (TSHR) AGONISTS TSHR, THRA, TRHR LHCGR 22/4885TSHR 1/4885FSHR 6/4885
US-20090203716-A1 Pyrimidine low molecular weight ligands for modulating hormone receptors FSHR, TSHR, TRHR LHCGR 5/4885TSHR 2/4885FSHR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.